Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: Paracrine regulation by carcinoma cell- derived members of the transforming growth factor β family

Cancer Research

Volumn 56, Issue 21, 1996, Pages 5063-5070

  Vrana, Julie A ^a,b   Stang, Michael T ^a   Grande, Joseph P ^a   Getz, Michael J ^a,c  

^a MAYO CLINIC   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD CLOTTING; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; STROMA CELL; TISSUE DISTRIBUTION;

ACTINS; ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MICE; MICE, INBRED AKR; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029854237     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Edgington, T. S., Mackman, N., Brand, K., and Ruf, W. The structural biology of expression and function of tissue factor. Thromb. Haemostasis, 66: 67-79, 1991.
2. Furie, B., and Furie, B. C. The molecular basis of blood coagulation. Cell, 53: 505-518, 1988.
3. Drake, T. A., Morrissey, J. H., and Edgington, T. S. Selective cellular expression of tissue factor in human tissues. Am. J. Pathol., 134: 1087-1097, 1989.
4. Carson, S. D., Henry, W. M., and Shows, T. B. Tissue factor gene localized to human chromosome 1 (1pter→1p21). Science (Washington DC), 229: 991-993, 1985.
5. Ranganathan, G., Blatti, S. P., Subramaniam, M., Fass, D. N., Maihle, N. J., and Getz, M. J. Cloning of murine tissue factor and regulation of gene expression by transforming growth factor type β1. J. Biol. Chem., 266: 496-501, 1991.
6. Hartzell, S., Ryder, K., Lanahan, A., Lau, L. F., and Nathans, D. A growth factor-responsive gene of murine BALB/c3T3 cells encodes a protein homologous to human tissue factor. Mol. Cell. Biol., 9: 2567-2573, 1989.
7. Morrissey, J. H., Gregory, S. A., Mackman, N., and Edgington, T. S. Tissue factor regulation and gene organization. Oxf Surv. Eukaryotic Genes, 6: 67-84, 1989.
8. Bazan, J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA, 87 6934-6938, 1990.
9. Zioncheck, T. F., Roy, S., and Vehar, G. A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J. Biol. Chem., 267: 3561-3564, 1992.
10. Sandset, P. M., Warn-Cramer, B. J., Rao, L. V. M., Maki, S. L., and Rapaport, S. I. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor evidence supporting a physiologic role for EPI as a natural anticoagulant Proc. Natl. Acad. Sci. USA, 88: 708-712, 1991.
11. Wilcox, J. N., Smith, K. M., Schwartz, S. M., and Gordon, D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA, 86: 2839-2843, 1989.
12. Taylor, F. B., Jr, Chang, A., Ruf, W., Morrissey, J. H., Hinshaw, L., Catlett, R., Blick, K., and Edgington, T. S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody Circ. Shock, 33: 127-134, 1991.
13. Rao, L. V. M. Tissue factor as a tumor procoagulant Cancer Metastasis Rev., 11: 249-266, 1992.
14. Trousseau, A. Phlegmasia alba dolens. In: J. B. Balliere et al. (eds), Clinique Medicale de l'Hotel-Dieu de Paris, pp. 654-712. Paris, 1865.
15. Rickles, F. R., Levine, M., and Edwards, R. L. Hemostatic alterations in cancer patients Cancer Metastasis Rev., 11: 237-248, 1992.
16. Callander, N. S., Varki, N., and Rao, L. V. M. Immunohistochemical identification of tissue factor in solid tumors Cancer (Phila.), 70: 1194-1201, 1992.
17. Chen, Z., and Sager, R. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol. Med., 1: 153-160, 1995.
18. Sturm, U., Luther, T., Albrecht, S., Flossel, C., Grossmann, H., and Muller, M. Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Virchows Arch. A Pathol. Anat. Histopathol., 421: 79-86, 1992.
19. Zacharski, L. R., Schned, A., and Sorenson, G. D. Occurrence of fibrin and tissue factor antigen in small cell carcinoma of the lung. Cancer Res., 43: 3963-3968, 1983.
20. Contrino, J., Hair, G., Kreutzer, D. L., and Rickles, F. R. In situ detection of tissue factor in vascular endothelial cells, correlation with the malignant phenotype of human breast disease Nat. Med., 2: 209-214, 1996.
21. Ronnov-Jessen, L., and Petersen, O. W. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Lab. Invest., 68: 696-707, 1993.
22. Gown, A. M. The mysteries of the myofibroblast (partially) unmasked Lab. Invest., 63: 1-3, 1990.
23. Page, D. L., and Japaze, H. Noninfiltrating (in situ) carcinoma In: K. I Bland and E. M. Copeland. III (eds), The breast: comprehensive management of benign and malignant diseases, pp 169-191 Philadelphia: W. B. Saunders Co., 1991.
24. Rowe, W. P., Hartley, J. W., Lander, M. R., Pugh, W. E., and Teich, N. Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus. Virology, 46: 866-876, 1971.
25. Tucker, R. F., Volkenant, M. E., Branum, E. L., and Moses, H. L. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells. Cancer Res., 43: 1581-1586, 1983.
26. Moses, H. L., Childs, C. B., Jaroslava, H., Shipley, G. D., and Tucker, R. F. Role of transforming growth factors in neoplastic transformation. In. C. M. Veneziale (ed.), Control of Cell Growth and Proliferation, pp. 147-167. New York: Van Nostrand-Reinhold, 1984.
27. Shipley, G. D., Tucker, R. F., and Moses, H. L. Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval. Proc. Natl. Acad. Sci. USA, 82: 4147-4151, 1985.
28. Hodgson, C. P., Elder, P. K., Ono, T., Foster, D. N., and Getz, M. J. Structure and expression of mouse VL30 genes. Mol. Cell. Biol., 3: 2221-2231, 1983.
29. Sappino, A. P., Schurch, W., and Gabbiani, G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest., 63: 144-161, 1990.
30. Woodcock-Mitchell, J., Eichner, R., Nelson, W. G., and Sun, T. T. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell. Biol., 95: 580-588, 1982.
31. Tseng, S. C., Jarvinen, M. J., Nelson, W. G., Huang, J. W., Woodcock-Mitchell, J., and Sun, T. T. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell, 30: 361-372, 1982.
32. Ruf, W., and Edgington, T. S. An anti-tissue factor monoclonal antibody which inhibits TF. VIIa complex is a potent anticoagulant in plasma. Thromb. Haemostasis, 66: 529-533, 1991.
33. Paborsky, L. R., and Harris, R. J. Post-translational modifications of recombinant human tissue factor. Thromb. Res., 60: 367-376, 1990.
34. Petersen, O. W., Hansen, S. H., Laursen, I., and vanDeurs, B. Effect of insulin on growth and expression of smooth muscle isoactin in human breast gland myoepithelial cells in a chemically defined culture system. Eur. J. Cell. Biol., 50: 500-509, 1989.
35. Pierson, K. K., and Wilkinson, E. J. Malignant neoplasia of the breast: infiltrating carcinomas. In: K. L. Bland and E. M. Copeland, III (eds.), The Breast: Comprehensive Management of Benign and Malignant Diseases, pp. 193-209. Philadelphia: W. B. Saunders Co., 1991.
36. Pusztai, L., Clover, L. M., Cooper, K., Starkey, P. M., Lewis, C. E., and McGee, J. O. Expression of tumour necrosis factor a and its receptors in carcinoma of the breast. Br. J. Cancer, 70: 289-292, 1994.
37. Walker, R. A., Dearing, S. J., and Gallacher, B. Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br. J. Cancer, 69: 1160-1165, 1994.
38. Hildenbrand, R., Dilger, I., Horlin, A., and Stutte, H. J. Urokinase and macrophages in tumour angiogenesis. Br. J. Cancer, 72: 818-823, 1995.
39. Schurch, W., Seemayer, T., and Gabbiani, G. Myofibroblast. In: S. Sternberg (ed.), Histology for Pathologists, pp. 109-144. New York: Raven Press, 1992.
40. Arnck, B. A., Korc, M., and Derynck, R. Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res., 50: 299-303, 1990.
41. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., and Dickson, R. B. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417-428, 1987.
42. Arteaga, C. L., Coffey, R. J., Jr., Dugger, T. C., McCutchen, C. M., Moses, H. L., and Lyons, R. M. Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies: evidence for negative autocrine regulation by transforming growth factor β. Cell Growth & Differ, 1: 367-374, 1990.
43. Desmoulière, A., Geinoz, A., Gabbiani, F., and Gabbiani, G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell. Biol., 122: 103-111, 1993.
44. Vrana, J. A., Schmidt, L. J., Fass, D. N., and Getz, M. J. Activation of tissue factor accompanies transforming growth factor type β1-stimulation of the myofibroblast phenotype in vitro Mol. Biol. Cell, 5: 385a, 1994.
45. Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., and Chambon, P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348: 699-704, 1990.
46. Riches, D. W. H. The multiple roles of macrophages in wound healing. In: R. A. F. Clark and P. M. Henson (eds.), The Molecular and Cellular Biology of Wound Repair, pp. 213-233 New York: Plenum Publishing Corp., 1988.
47. Rambaldi, A., Alessio, G., Casali, B., Passerini, C. G., Donati, M. B., Mantovani, A., and Semeraro, N. Induction of monocyte-macrophage procoagulant activity by transformed cell lines. J. Immunol., 136; 3848-3855, 1986.
48. Sappino, A. P., Skalli, O., Jackson, B., Schurch, W., and Gabbiani, G. Smooth-muscle differentiation in stromal cells of malignant and nonmalignant breast tissues. Int. J. Cancer. 41: 707-712, 1988.
49. Scanlan, M. J., Mohan Raj, B. K., Calvo. B., Garin-Chesa, P., Sanz-Moncasi, M. P., Healy, J. H., Old, L. J., and Rettig, W. J. Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. USA, 91: 5657-5661, 1994.
50. Dvorak, H. F. Tumors: wounds that do not heal. N. Engl. J. Med., 315: 1650-1659, 1986.
51. Lazard, D., Sastre, X., Frid, M. G., Glukhova, M. A., Thiery, J.-P., and Koteliansky, V. E. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc. Natl. Acad. Sci. USA, 90: 999-1003, 1993.
52. Schurch, T. A., Seemayer, T. A., and Lagace, R. Stromal myofibroblasts in primary invasive and metastatic carcinomas. Virchows Arch. A Pathol. Anat., 391: 125-139, 1981.
53. Skalli, O., and Gabbiani, G. The biology of the myofibroblast Relationship to wound contraction and fibrocontractive diseases In: R. A. F. Clark and P. M. Henson (eds), The Molecular and Cellular Biology of Wound Repair, pp. 373-394. New York: Plenum Publishing Corp., 1988.
54. Ronnov-Jessen, L., Petersen, O. W., Koteliansky, V. E., and Bissell, M. J. The origin of the myofibroblasts in breast cancer. J. Clin. Invest., 95: 859-873, 1995.
55. Walker, R. A., and Dearing, S. J. Transforming growth factor β in ductal carcinoma in situ and invasive carcinomas of the breast. Eur. J. Cancer, 28: 641-644, 1992.
56. Dalal, B. I., Keown, P. A., and Greenberg, A. H. Immunocytochemical localization of secreted transforming growth factor-β1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma Am. J. Pathol., 143: 381-389, 1993.
57. Postlethwaite, A. E., Keski-oja, J., Moses, H. L., and Kang, A. H. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J. Exp. Med., 165: 251-256, 1987.
58. Karrar, A. K., Lemoine, N. R., Scully, M. F., Tebbutt, S., and Williamson, R. C. N. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J. Surg., 82: 1101-1104, 1995.
59. Mueller, B. M., Reisfeld, R. A., Edgington, T. S., and Ruf, W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc. Natl. Acad. Sci. USA, 89: 11832-11836, 1992.
60. Bromberg, M. E., Konigsberg, W. H., Madison, J. F., Pawashe, A., and Garen, A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA, 92: 8205-8209, 1995.
61. Zhang, Y., Deng, Y., Luther, T., Muller, M., Ziegler, R., Waldherr, R., Stern, D. M., and Nawroth, P. P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J. Clin Invest. 94: 1320-1327, 1994.
62. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roch, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., and Fauci, A. S. Transforming growth factor type β rapid induction of fibrosis and angiogenesis in vivo and collagen formation in vitro Proc. Natl. Acad. Sci. USA, 83: 4167-4171, 1986.
63. Dvorak, H. F., Senger, D. R., and Dvorak, A. M. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev., 2: 41-73, 1983.